Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs

Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Home
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Podcast
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Interviews
    • Meetings reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs

  • Home
  • Pharmaceuticals
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • AdobeStock_540926170
      Gene therapy gives
      hope to patients
      with ‘butterfly skin’
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • NUTRACEUTICALS
      Regulatory guidelines for
      nutraceuticals in India
  • Veterinary
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • AdobeStock_223465811 (1)
      First anaemia drug for cats given
      ‘expanded conditional approval’
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • Understanding the key components of a clinical evaluation
      Understanding key components
      of a clinical evaluation
    • AdobeStock_497948986 (1)
      Successful transition of your ISO 13485 QMS from MDD/IVDD to MDR/IVDR
  • Industry news
      • Industry news
        • Read latest news
        • Podcast
        • Video
    • Podcast-artwork-Webvision
      Conversations:
      Regulating Vaxzevria:
      The world’s first COVID-19 vaccine
    • AdobeStock_577204899
      Illegal vapes found
      to contain lead and
      nickel: TOPRA Fellow
    • AdobeStock_540926170
      Gene therapy gives
      hope to patients
      with ‘butterfly skin’
  • Commentary
      • Editorials
      • Letters to the Editor
    • Legalise-Cannabis
      Part 4. UK routes to registration for medicinal cannabis
    • Cannabis&Doctors
      Part 3. The medical applications of cannabis
    • Cannabis&Law
      Part 2. Regulatory background of medicinal cannabis in EU and UK
  • Collections
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Interviews
      • Meetings reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More navigation items
Podcast
RR-Pod-April-23-1920x1080-brand-colours - PODCAST ARTWORK

April 2023

By Alan Booth

  • No comments

Vol. 20 #4

The first episode of RegRapPod, our new Regulatory Rapporteur podcast series, is available to listen to now. Hosted by Managing Editor Alan Booth, our April Issue Editor Vickie Goff discusses the main focus topic of Latin America. We also hear from authors Priti Shah and Anna Litsiou who share some of the main insights from their article about the regulatory process of AstraZeneca’s COVID-19 vaccine.

Topics

  • Covid-19
  • Latin America
  • SARS-Cov-2
  • Vaccine

Latest audio

  • Podcast-artwork-Webvision

    Conversations:
    Regulating Vaxzevria:
    The world’s first COVID-19 vaccine

Related articles

  • AdobeStock_230079150
    Industry news

    HIV-prevention drug is first to be made in South Africa

    2023-05-25T10:33:00Z

    Indian firm Cipla is first manufacturer approved to produce generic of the
    HIV-preventer cabotegravir, in South Africa.

  • Dr. Tedros Adhanom Ghebreyesus
    Industry news

    WHO says COVID-19 ‘no longer a global health emergency’

    2023-05-05T14:31:00Z

    SARS-Cov-2 – which caused the COVID-19 pandemic – “no longer a public health emergency of international concern”: WHO.

  • Does sole dependence on reliance models contribute to a sustainable healthcare ecosystem?
    Journal

    Does sole dependence on reliance models contribute to a sustainable healthcare ecosystem?

    2023-04-06T08:00:00Z

    Governments should strive for a sustainable and global regulatory framework adept to deal with a healthcare crisis and similar issues that may arise in the future. This article looks at regulatory frameworks in international regions through AstraZeneca’s experience with the VaxzevriaTM vaccine.

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register

More Podcast

  • Podcast-artwork-Webvision
    Podcast

    Conversations:
    Regulating Vaxzevria:
    The world’s first COVID-19 vaccine

    Vol. 20 #4
    MEMBER EXCLUSIVE: 
    Hosted by Alan Booth, managing editor of Regulatory Rapporteur, this episode of RegRapPod  is an extended conversation with authors Priti Shah and Anna Litsiou following on from their article in the April issue [Vol. 20 #4]. Priti and Anna share insights around the regulatory process of AstraZeneca’s COVID-19 vaccine - Vaxzevria.

  • Regulatory Rapporteur Editorial board
  • Future focus topics
  • Glossary
  • Privacy policy
  • Search the archive
  • TOPRA membership
  • What is regulatory affairs?
  • ISSN 1742-8955

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Issues
  • Contact us
  • Topics A-Z
  • Contributors A-Z
  • Copyright © 2023 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud